Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma
More personalized treatment strategies and biomarker-guided approaches may further refine GLP1 MASLD MASH treatment in the near future
It delivers high-quality protein (~1718g per serve), a low-GI formulation designed to support stable glucose levels, dietary fibre, probiotics, and targeted micronutrients including chromium, zinc, vitamin D, and inositol all in a rich chocolate flavour thats easy to consume even on reduced appetite days
Tirzepatide (Mounjaro, Zepbound) works similarly but is classified as a dual GIP/GLP-1 receptor agonist
Vivek Lal to improve respiratory structure and function, support gut health and better sleep